Clinical Trial Detail

NCT ID NCT03543189
Title Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

prostate cancer

Therapies

Nivolumab

Age Groups: adult senior

No variant requirements are available.